Health and Fitness

Clinical Trial Analysis Suggests Drug Combination May Be Highly Effective in Recurrent Ovarian Cancer

Bethesda, Maryland--(ENEWSPF)--June 2, 2014.  Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology meeting in Chicago. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The drugs were tested in a phase I combination study followed by a randomized phase 2 trial sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health.

The trial compared the activity of a combination of the drug . . .

STEEL MAGNOLIAS is coming to The Drama Group

First Trustee Forum

First Mayoral Forum

Please follow & like us :)

ARCHIVES